Table 1.
Patients’ general characteristics and clinicopathological features of the disease.
| Studied variable | Healthy controls N = 62 No (%) |
Malignant group N = 62 No (%) |
Metastatic group N = 62 No (%) |
P-value |
|---|---|---|---|---|
| Age | ||||
| Mean ± SD | 53.9 ± 10.25 | 54.37 ± 12.8 | 55.74 ± 11.33 | 0.65 |
| Median | 53.00 | 54.0 | 55.00 | |
| Min–max | 22–77 | 28–81 | 31–83 | |
| Hypertension | 7 (11.3) | 23 (37.1) | 27 (43.5) | <0.001 |
| Diabetes | 6 (9.7) | 16 (25.8) | 18 (29.0) | 0.02 |
| BMI | 0.37 | |||
| Mean ± SD | 31.26 ± 6.14 | 32.88 ± 5.97 | 31.93 ± 6.86 | |
| Median | 30.0 | 33.50 | 32.00 | |
| Min–max | 22–51 | 22–55 | 2–45 | |
| Family history | ||||
| Positive | 21 (33.9) | 14 (22.6) | 15 (22.4) | 0.20 |
| Menopausal status | ||||
| Pre | 21 (33.9) | 27 (43.5) | 28 (45.2) | 0.8 |
| Post | 41 (66.1) | 35 (56.5) | 33 (53.2) | |
| Usage of hormonal contraception | 13 (21.0) | 25 (40.3) | 30 (48.4) | 0.005 |